Medistim ASA (OSL:MEDI) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:MEDI Medistim ASA OSL:MEDI
88 GF Score
Price kr230.00
GF Value kr259.67
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medistim ASA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


OSL:MEDI vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Medistim ASA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Short Interest distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Short Interest falls into.


OSL:MEDI
88GF Score
Medistim ASA OSL:MEDI
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medistim ASA (OSL:MEDI) Overvalued in 2026?

Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued. The current stock price of kr230.00 is trading 11.4% below its estimated GF Value™ of kr259.67. GuruFocus considers Medistim ASA to be Modestly Undervalued.

Key valuation signals for OSL:MEDI:

  • Short Interest:
  • GF Value™: kr259.67 vs. price of kr230.00 (11.4% below fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the OSL:MEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medistim ASA Business Description

Address Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
88GF Score

Get the complete analysis for OSL:MEDI

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr230.00
Price
kr259.67
GF Value